Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial

Int J Clin Exp Hypn. 2008 Jul;56(3):270-80. doi: 10.1080/00207140802039672.

Abstract

This study evaluated the benefits of add-on hypnotherapy in patients with chronic PTSD. Thirty-two PTSD patients treated by SSRI antidepressants and supportive psychotherapy were randomized to 2 groups: 15 patients in the first group received Zolpidem 10 mg nightly for 14 nights, and 17 patients in the hypnotherapy group were treated by symptom-oriented hypnotherapy, twice-a-week 1.5-hour sessions for 2 weeks. All patients completed the Stanford Hypnotic Susceptibility Scale, Form C, Beck Depression Inventory, Impact of Event Scale, and Visual Subjective Sleep Quality Questionnaire before and after treatment. There was a significant main effect of the hypnotherapy treatment with PTSD symptoms as measured by the Posttraumatic Disorder Scale. This effect was preserved at follow-up 1 month later. Additional benefits for the hypnotherapy group were decreases in intrusion and avoidance reactions and improvement in all sleep variables assessed.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Combat Disorders / diagnosis
  • Combat Disorders / psychology
  • Combat Disorders / therapy*
  • Combined Modality Therapy
  • Dreams* / drug effects
  • Humans
  • Hypnosis*
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / therapeutic use*
  • Male
  • Night Terrors / diagnosis
  • Night Terrors / psychology
  • Night Terrors / therapy*
  • Psychotherapy
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Serotonin Uptake Inhibitors / therapeutic use
  • Sleep Initiation and Maintenance Disorders / psychology
  • Sleep Initiation and Maintenance Disorders / therapy*
  • Young Adult
  • Zolpidem

Substances

  • Hypnotics and Sedatives
  • Pyridines
  • Serotonin Uptake Inhibitors
  • Zolpidem